TD Waterhouse Canada’s Ventyx Biosciences VTYX Stock Holding History

TD Waterhouse Canada’s Portfolio VTYX Stock Details VTYX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-1,060	Closed	-$42.3K	–	1804
2023 Q2	$42.3K	Hold	1,060	–	–	﹤0.01%	976
2023 Q1	$42.6K	Buy	1,060 +288	+37%	+$11.2K	﹤0.01%	938
2022 Q4	$27.3K	Buy	+772	New	+$22.9K	﹤0.01%	1027

Other funds holding VTYX

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return

TD Waterhouse Canada's VTYX Position: Q3 2023 in Review

TD Waterhouse Canada sold out of Ventyx Biosciences (VTYX) in Q3 2023, closing a stake of 1,060 shares — an estimated $42.3K sold.

TD Waterhouse Canada first reported a position in VTYX in Q4 2022 and held it in 3 quarters. The position peaked at $42.6K in Q1 2023. 138 funds tracked by Wall St. Rank hold VTYX as of Q3 2023.

TD Waterhouse Canada reported no remaining Ventyx Biosciences position as of Q3 2023 after selling out during the quarter.
TD Waterhouse Canada sold 1,060 Ventyx Biosciences shares in Q3 2023, an estimated $42.3K.
TD Waterhouse Canada first reported a position in Ventyx Biosciences in Q4 2022 and held it in 3 quarters.
TD Waterhouse Canada's Ventyx Biosciences position peaked at $42.6K in Q1 2023.
138 funds tracked by Wall St. Rank held Ventyx Biosciences as of Q3 2023.

Based on TD Waterhouse Canada's 13F filing for Q3 2023, filed 13 Nov 2023.